[Sulodexide treatment in retinal vein obstructions].
Retinal vein occlusion (RVO) represents one of the most frequent vascular disorders of the posterior pole. RVO treatment is disappointing because a great number of patients remains with a reduced visual acuity; the visual acuity is the functional test which shows the treatment efficacity. The study group of patients was treated with sulodexid, a therapeutic agent with thrombolytic and fibrinolytic action; sulodexid was associated with laser photocoagulation where it was required. Study's results point out efficiency only for those cases treated precociously between 48 to 72 hours from the outset.
Corbu
C
C
Spitalul Clinic de Oftalmologie, Bucureşti.
Predoi
D
D
Goicea
D
D
D000328:Adult; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D014792:Visual Acuity / Q000187:drug effects
D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; C007858:glucuronyl glucosamine glycan sulfate
Tratamentul cu sulodexid în obstrucţiile venoase retiniene.